Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medartis Holding AG
  6. Summary
    MED   CH0386200239

MEDARTIS HOLDING AG

(MED)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
109.6(c) 108(c) 109.8(c) 108.4(c) 107.6(c) Last
6 966 15 157 7 288 8 790 10 792 Volume
+4.38% -1.46% +1.67% -1.28% -0.74% Change
More quotes
Estimated financial data (e)
Sales 2021 148 M 161 M 161 M
Net income 2021 8,53 M 9,30 M 9,30 M
Net cash position 2021 65,3 M 71,2 M 71,2 M
P/E ratio 2021 149x
Yield 2021 -
Sales 2022 170 M 185 M 185 M
Net income 2022 14,3 M 15,6 M 15,6 M
Net cash position 2022 73,9 M 80,5 M 80,5 M
P/E ratio 2022 88,3x
Yield 2022 -
Capitalization 1 271 M 1 383 M 1 385 M
EV / Sales 2021 8,17x
EV / Sales 2022 7,04x
Nbr of Employees 649
Free-Float 33,2%
More Financials
Company
Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such... 
More about the company
Ratings of Medartis Holding AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about MEDARTIS HOLDING AG
11/10Medartis CEO Affirms Upgraded Sales Growth Guidance of 20%, Looks to Revise China Strat..
MT
09/20MEDARTIS HOLDING AG(SWX : MED) added to S&P Global BMI Index
CI
08/17Medartis Holding AG Raises Earnings Guidance for the Full Year 2021
CI
08/17Medartis Holding Ag Reports Earnings Results for the Half Year Ended June 30, 2021
CI
04/23MEDARTIS HOLDING AG : Annual General Meeting approves all proposals of the Board of Direct..
EQ
04/23Medartis Holding AG Approves Election of Marco Gadola as Chairman of the Board of Direc..
CI
03/30MEDARTIS : Bryan Garnier Lifts Price Target on Medartis, Maintains Buy Recommendation
MT
03/10MEDARTIS : Chairman to Step Down; Successor Selected
MT
03/10MEDARTIS : Swings to FY20 Loss on Higher Taxes
MT
03/10MEDARTIS HOLDING AG : Medartis achieves solid full-year 2020 result and nominates new Chai..
PU
03/10MEDARTIS HOLDING AG : Medartis achieves solid full-year 2020 result and nominates new Chai..
EQ
03/10Medartis Holding Ag Reports Earnings Results for the Full Year Ended December 31, 2020
CI
03/10Medartis Holding AG Provides Earnings Guidance for the Full Year 2021
CI
03/02MEDARTIS : | Invitation Media and Investor conference | 2020 annual results
PU
03/02MEDARTIS : | Invitation Media and Investor conference | 2020 annual results
EQ
More news
News in other languages on MEDARTIS HOLDING AG
11/23AKTIEN SCHWEIZ SCHLUSS : Gewinnmitnahmen auf breiter Front
11/11AKTIEN SCHWEIZ SCHLUSS : Starke Sika-Aktien heben Gesamtmarkt nach oben
11/11AKTIEN SCHWEIZ : Gesamtmarkt dank Sika fester
11/10Le PDG de Medartis confirme la révision à la hausse de ses prévisions de croissance du ..
11/10Medartis-CEO bestätigt Guidance und überarbeitet China-Strategie
More news
Analyst Recommendations on MEDARTIS HOLDING AG
More recommendations
Chart MEDARTIS HOLDING AG
Duration : Period :
Medartis Holding AG Technical Analysis Chart | MED | CH0386200239 | MarketScreener
Technical analysis trends MEDARTIS HOLDING AG
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 107,60 CHF
Average target price 82,50 CHF
Spread / Average Target -23,3%
EPS Revisions
Managers and Directors
Christoph Br÷nnimann Chief Executive Officer
Dirk W. Kirsten Chief Financial Officer
Marco Gadola Chairman
Manuel Schaer Chief Technology Officer
JŘrg Greuter Independent Non-Executive Director
Sector and Competitors